Dasatinib-based induction and blinatumomab + TKI consolidation/maintenance for BCR::ABL1+ ALL: BLISSPhALL Study Results
Authors:
- Mark B. GeyerMGMark B. Geyer
- John MascarenhasJMJohn Mascarenhas
- Michal Bar-NatanMBMichal Bar-Natan
- Marissa SmithMSMarissa Smith
- Shakira PascualSPShakira Pascual
- Anmol ShahASAnmol Shah
- Michael R. SilvestroneMSMichael R. Silvestrone
- Kenton WuKWKenton Wu
- Hannah LevaviHLHannah Levavi
- Tina CzaplinskaTCTina Czaplinska
- Kathryn JohnsonKJKathryn Johnson
- Meghan C. ThompsonMTMeghan C. Thompson
Open Access
- 29 September 2026
- journal article
- Published by Elsevier in Blood Neoplasia
Abstract
No abstract availableFunding Information
- Amgen
- National Cancer Institute